Maternal immunization provides vaccine-specific immunity to the infant via breast milk.
Multiple studies have reported the presence of SARS-CoV-2 antibodies in human breast milk (HBM) from infected and/or vaccinated women.
However, there is limited information on the analytical performance, consistency, and quality of the methods used.
Standardized and rigorous assays are needed to meet clinical study endpoints and for comparisons across studies.
